Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer
Completed · Phase 1/Phase 2
Conditions studied: Colorectal Cancer
In brief
RATIONALE: Radiation therapy uses high energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy plus irinotecan in treating patients with colon cancer that is recurrent or that cannot be removed surgically.
Key facts
- Study ID
- NCT00003344
- Run by
- Medical University of South Carolina
- People needed
- 49
- Starts
- 1998-08-01
- Expected to finish
- 2000-01-01
- Last updated by the study team
- 2018-05-16
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.